SLNO Financials
Soleno Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$2.76B
P/E Ratio
27.5
Balance Sheet Highlights
Total Assets
$330.97M
Total Liabilities
$85.86M
Shareholders Equity
-
Cash & Equivalents
$87.93M
Total Debt
-
Profitability Metrics
Net Margin
33.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SLNO revenue?
View SLNO's income statement for detailed revenue data.
Is SLNO profitable?
Check SLNO's income statement for profitability data.
What is SLNO market cap?
SLNO has a market capitalization of $2.76B, making it a mid-cap stock.
Does SLNO have debt?
View SLNO's balance sheet for debt information.
What is SLNO cash flow?
Cash flow data is available in the full financial statements.